Managing refractory angina – is exercise with co-administered heparin the solution?

Knuuti J Wijns W Saraste A , et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407–477.

Mannheimer C Camici P Chester MR , et al. The problem of chronic refractory angina: Report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002; 23: 355–370.

Sainsbury PA Fisher M de Silva R. Alternative interventions for refractory angina. Heart 2017; 103: 1911–1922.

Henry TD Satran D Hodges JS , et al. Long-term survival in patients with refractory angina. Eur Heart J 2013; 34: 2683–2688.

Cheng K Sainsbury P Fisher M , et al. Management of refractory angina pectoris. Eur Cardiol Rev 2016; 11: 69.

Piepoli MF Hoes AW Agewall S , et al.; ESC Scientific Document Group. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016; 37: 2315–2381.

Henry TD, Satran HD Jolicoeur EM. Treatment of refractory angina in patients not suitable for revascularization. Nat Rev Cardiol 2014; 11: 78–95.

Gallone G Baldetti L Tzanis G , et al. Refractory angina. from pathophysiology to new therapeutic nonpharmacological technologies. JACC: Cardiovasc Interv 2019; 13: 1–19.

Petrovic MT Djordjevic-Dikic A Giga V , et al. The Coronary Arteriogenesis with combined Heparin and Exercise therapy in chronic refractory Angina (CARHEXA) trial: A double-blind, randomized, placebo-controlled stress echocardiographic study. Eur J Prev Cardiol 2020; Epub ahead of print, DOI: 10.1177/2047487320915661.

Fujita M. Heparin and angiogenic therapy. Eur Heart J 2000; 21: 270–274.

Bhakuni T, Ali MF, Ahmad I, et al. Role of heparin and non heparin binding sermons in coagulation and angiogenesis: A complex interplay. Arch Biochem Biophys 2016; 128–142.

Folkman J Klagsbrun M Sasse J , et al. A heparinbinding angiogenic protein–basic fibroblast growth factor–is stored within basement membrane. Am J Pathol 1988; 130: 393–400.

Awada HK Johnson NR Wang Y. Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects. Macromol Bio Sci 2014; 14: 679–686.

Zhang J Li Y Li M , et al. Collateral vessel opacification with CT in patients with coronary total occlusion and its relationship with downstream myocardial infarction. Radiology 2014; 271: 703–710.

Rentrop KP Cohen M Blanke H , et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587–592.

Pastormerlo LE Aimo A Piepoli M , et al. The bottleneck of cardiac rehabilitation for patients with coronary artery disease: How to overcome. Eur J Prev Cardiol 2018; 25: 1239–1241.